Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF

NCT00583921 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-07-13

No results posted yet for this study

Summary

Single center investigator initiated sponsored by Guidant Boston Scientific Corp. to evaluate the benefit of ventricular rate regularization (VRR) in patients with congestive heart failure (CHF) and significant atrial fibrillation (AF) burden.

Conditions

Sponsors & Collaborators

  • Guidant Corporation

    collaborator INDUSTRY
  • University of California, Davis

    lead OTHER

Principal Investigators

  • Uma Srivatsa, MD · U C Davis Medical Center

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00583921 on ClinicalTrials.gov